Psilocybin, Lysergic Acid Diethylamide, Mescaline, and Drug-Induced Synesthesia

Berit Brogaard, Dimitria Electra Gatzia

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Studies have shown that both serotonin and glutamate receptor systems play a crucial role in the mechanisms underlying drug-induced synesthesia. The specific nature of these mechanisms, however, continues to remain elusive. Here we propose two distinct hypotheses for how synesthesia triggered by hallucinogens in the serotonin agonist family may occur. One hypothesis is that the drug-induced destabilization of thalamic projections via ?-aminobutyric acidergic neuronal circuits from sensory areas leads to a disruption of low-level, spontaneous integration of multisensory stimuli. This sort of integration regularly occurs when spatial and temporal attributes match. Destabilization of feedback loops, however, can result in incongruent experiences or binding of random thalamus activation with sensory input in a particular sensory modality. The second hypothesis builds on embodied cognition, cases in which visual images of external stimuli activate task-related neural regions. In this proposal, binding processes that do not normally generate awareness become accessible to consciousness as a result of decreased attentional discrimination among incoming stimuli.

Original languageEnglish (US)
Title of host publicationStimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects
PublisherElsevier Inc.
Pages890-905
Number of pages16
Volume2
ISBN (Print)9780128003756, 9780128002124
DOIs
StatePublished - Apr 15 2016

Fingerprint

Psilocybin
Mescaline
Lysergic Acid Diethylamide
Hallucinogens
Serotonin Receptor Agonists
Serotonin Receptors
Glutamate Receptors
Consciousness
Thalamus
Pharmaceutical Preparations
Cognition
Synesthesia

Keywords

  • 5-HT serotonin receptors
  • Anxiety disorder
  • Attentional discrimination
  • Depression
  • Drug-induced hallucinations
  • Drug-induced synesthesia
  • Embodied cognition
  • Glutamate receptor system
  • Hallucinogens
  • LSD
  • Mescaline
  • Psilocybin
  • Psychedelics
  • Sensory modality
  • Serotonin agonist

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Brogaard, B., & Gatzia, D. E. (2016). Psilocybin, Lysergic Acid Diethylamide, Mescaline, and Drug-Induced Synesthesia. In Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects (Vol. 2, pp. 890-905). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800212-4.00083-2

Psilocybin, Lysergic Acid Diethylamide, Mescaline, and Drug-Induced Synesthesia. / Brogaard, Berit; Gatzia, Dimitria Electra.

Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects. Vol. 2 Elsevier Inc., 2016. p. 890-905.

Research output: Chapter in Book/Report/Conference proceedingChapter

Brogaard, B & Gatzia, DE 2016, Psilocybin, Lysergic Acid Diethylamide, Mescaline, and Drug-Induced Synesthesia. in Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects. vol. 2, Elsevier Inc., pp. 890-905. https://doi.org/10.1016/B978-0-12-800212-4.00083-2
Brogaard B, Gatzia DE. Psilocybin, Lysergic Acid Diethylamide, Mescaline, and Drug-Induced Synesthesia. In Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects. Vol. 2. Elsevier Inc. 2016. p. 890-905 https://doi.org/10.1016/B978-0-12-800212-4.00083-2
Brogaard, Berit ; Gatzia, Dimitria Electra. / Psilocybin, Lysergic Acid Diethylamide, Mescaline, and Drug-Induced Synesthesia. Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects. Vol. 2 Elsevier Inc., 2016. pp. 890-905
@inbook{b4751ea9b1ea44ce942f71a3db6555f4,
title = "Psilocybin, Lysergic Acid Diethylamide, Mescaline, and Drug-Induced Synesthesia",
abstract = "Studies have shown that both serotonin and glutamate receptor systems play a crucial role in the mechanisms underlying drug-induced synesthesia. The specific nature of these mechanisms, however, continues to remain elusive. Here we propose two distinct hypotheses for how synesthesia triggered by hallucinogens in the serotonin agonist family may occur. One hypothesis is that the drug-induced destabilization of thalamic projections via ?-aminobutyric acidergic neuronal circuits from sensory areas leads to a disruption of low-level, spontaneous integration of multisensory stimuli. This sort of integration regularly occurs when spatial and temporal attributes match. Destabilization of feedback loops, however, can result in incongruent experiences or binding of random thalamus activation with sensory input in a particular sensory modality. The second hypothesis builds on embodied cognition, cases in which visual images of external stimuli activate task-related neural regions. In this proposal, binding processes that do not normally generate awareness become accessible to consciousness as a result of decreased attentional discrimination among incoming stimuli.",
keywords = "5-HT serotonin receptors, Anxiety disorder, Attentional discrimination, Depression, Drug-induced hallucinations, Drug-induced synesthesia, Embodied cognition, Glutamate receptor system, Hallucinogens, LSD, Mescaline, Psilocybin, Psychedelics, Sensory modality, Serotonin agonist",
author = "Berit Brogaard and Gatzia, {Dimitria Electra}",
year = "2016",
month = "4",
day = "15",
doi = "10.1016/B978-0-12-800212-4.00083-2",
language = "English (US)",
isbn = "9780128003756",
volume = "2",
pages = "890--905",
booktitle = "Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Psilocybin, Lysergic Acid Diethylamide, Mescaline, and Drug-Induced Synesthesia

AU - Brogaard, Berit

AU - Gatzia, Dimitria Electra

PY - 2016/4/15

Y1 - 2016/4/15

N2 - Studies have shown that both serotonin and glutamate receptor systems play a crucial role in the mechanisms underlying drug-induced synesthesia. The specific nature of these mechanisms, however, continues to remain elusive. Here we propose two distinct hypotheses for how synesthesia triggered by hallucinogens in the serotonin agonist family may occur. One hypothesis is that the drug-induced destabilization of thalamic projections via ?-aminobutyric acidergic neuronal circuits from sensory areas leads to a disruption of low-level, spontaneous integration of multisensory stimuli. This sort of integration regularly occurs when spatial and temporal attributes match. Destabilization of feedback loops, however, can result in incongruent experiences or binding of random thalamus activation with sensory input in a particular sensory modality. The second hypothesis builds on embodied cognition, cases in which visual images of external stimuli activate task-related neural regions. In this proposal, binding processes that do not normally generate awareness become accessible to consciousness as a result of decreased attentional discrimination among incoming stimuli.

AB - Studies have shown that both serotonin and glutamate receptor systems play a crucial role in the mechanisms underlying drug-induced synesthesia. The specific nature of these mechanisms, however, continues to remain elusive. Here we propose two distinct hypotheses for how synesthesia triggered by hallucinogens in the serotonin agonist family may occur. One hypothesis is that the drug-induced destabilization of thalamic projections via ?-aminobutyric acidergic neuronal circuits from sensory areas leads to a disruption of low-level, spontaneous integration of multisensory stimuli. This sort of integration regularly occurs when spatial and temporal attributes match. Destabilization of feedback loops, however, can result in incongruent experiences or binding of random thalamus activation with sensory input in a particular sensory modality. The second hypothesis builds on embodied cognition, cases in which visual images of external stimuli activate task-related neural regions. In this proposal, binding processes that do not normally generate awareness become accessible to consciousness as a result of decreased attentional discrimination among incoming stimuli.

KW - 5-HT serotonin receptors

KW - Anxiety disorder

KW - Attentional discrimination

KW - Depression

KW - Drug-induced hallucinations

KW - Drug-induced synesthesia

KW - Embodied cognition

KW - Glutamate receptor system

KW - Hallucinogens

KW - LSD

KW - Mescaline

KW - Psilocybin

KW - Psychedelics

KW - Sensory modality

KW - Serotonin agonist

UR - http://www.scopus.com/inward/record.url?scp=84969630986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969630986&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800212-4.00083-2

DO - 10.1016/B978-0-12-800212-4.00083-2

M3 - Chapter

SN - 9780128003756

SN - 9780128002124

VL - 2

SP - 890

EP - 905

BT - Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects

PB - Elsevier Inc.

ER -